Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...
MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.
NEWS RELEASE: ten23 health QC lab to support commercial product testing for U.S. customer following FDA approvals Basel, Switzerland — ten23 health, the ten23 health says its Basel and Visp QC ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Study demonstrated early and sustained hematopoietic recovery and transfusion independence Omisirge is a new and novel transplant option for patients with SAA Additional manufacturing capacity for ...